| 1.1 RM + UC: exacerbations: number of people experiencing 1 or more exacerbations |
1 |
|
Odds Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 1.1.1 6 to < 12 months |
1 |
|
Odds Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 1.2 RM + UC: exacerbations: mean number of exacerbations (subgroup duration) |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 1.2.1 6 to < 12 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 1.2.2 ≥ 12 months |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 1.3 RM + UC: quality of life: SGRQ total (subgroup duration) |
3 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 1.3.1 6 to < 12 months |
2 |
204 |
Mean Difference (IV, Random, 95% CI) |
‐1.49 [‐9.43, 6.44] |
| 1.3.2 ≥ 12 months |
1 |
205 |
Mean Difference (IV, Random, 95% CI) |
0.90 [‐3.71, 5.51] |
| 1.4 RM + UC: hospital service utilisation: mean hospital admissions (all‐cause) (single) |
3 |
342 |
Mean Difference (IV, Random, 95% CI) |
0.09 [‐0.43, 0.60] |
| 1.5 RM + UC: hospital service utilisation: hospital admissions (COPD‐related) |
3 |
400 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.01 [‐0.21, 0.18] |
| 1.6 RM + UC: hospital service utilisation: hospital admission rate ratio (GIV) |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.7 RM + UC: hospital service utilisation: HR: time to first hospitalisation after start of intervention |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.8 RM + UC: hospital service utilisation: hospital admissions (COPD‐related) (hazard ratio) |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.9 RM + UC vs UC: hospital use: time to first COPD‐related re‐admission |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.10 RM + UC: hospital use: time to first COPD‐related ED visit |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.11 RM + UC: hospital service utilisation: length of stay (all‐cause) |
4 |
604 |
Mean Difference (IV, Random, 95% CI) |
‐0.81 [‐4.83, 3.22] |
| 1.12 RM + UC: hospital service utilisation: length of stay (all‐cause) (hazard ratio) |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.13 RM + UC: hospital service utilisation: length of stay (COPD‐related) |
3 |
618 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.11 [‐0.30, 0.09] |
| 1.14 RM + UC: hospital service utilisation: length of stay (COPD‐related) (hazard ratio) |
1 |
|
Hazard Ratio (IV, Random, 95% CI) |
Totals not selected |
| 1.15 RM + UC: mortality (all‐cause) |
7 |
927 |
Odds Ratio (M‐H, Random, 95% CI) |
0.99 [0.62, 1.58] |
| 1.16 RM + UC: A/D: HADS anxiety (change from baseline, mean difference between groups) |
4 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 1.16.1 26 weeks |
2 |
|
Mean Difference (IV, Random, 95% CI) |
1.86 [0.68, 3.04] |
| 1.16.2 52 weeks |
2 |
|
Mean Difference (IV, Random, 95% CI) |
0.32 [‐0.47, 1.10] |
| 1.17 RM + UC: A/D: HADS depression (change from baseline, mean difference between groups) (single) |
3 |
577 |
Mean Difference (IV, Random, 95% CI) |
‐0.00 [‐0.76, 0.76] |
| 1.17.1 26 weeks |
1 |
110 |
Mean Difference (IV, Random, 95% CI) |
‐0.63 [‐2.05, 0.79] |
| 1.17.2 52 weeks |
2 |
467 |
Mean Difference (IV, Random, 95% CI) |
0.23 [‐0.68, 1.13] |
| 1.18 RM + UC: self‐efficacy: self‐efficacy for managing chronic disease (6‐item scale) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Totals not selected |
| 1.19 RM + UC: hospital service utilisation: length of stay (COPD‐related) (subgroup duration) |
3 |
618 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.11 [‐0.30, 0.09] |
